PDGFRB and hepatocellular carcinoma: This study explored the relationships between expression of VEGFR-2, PDGFR-β, and c-Met and the clinicopathological factors and prognosis of HCC patients, aiming to provide reference information to assist with the diagnosis, evaluation of prognosis, and targeted therapy of HCC.